Bank of America’s AngioDynamics ANGO Stock Holding History

Bank of America’s Portfolio ANGO Stock Details ANGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	–	Sell	-3,600	Closed	-$59K	–	7980
2014 Q2	$59K	Buy	+3,600	New	+$52.1K	﹤0.01%	6527

Other funds holding ANGO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

SFM

Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return

Broadfin Holdings Melville, New York $23.5M AUM

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

WCM

Weber Capital Management San Francisco, California $100M AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BAM

Bastion Asset Management Montreal, Canada $295M AUM 19.08% 1-Year Est. Return

Bank of America's ANGO Position: Q1 2026 in Review

Bank of America increased its AngioDynamics (ANGO) stake by 263% in Q1 2026, buying an estimated $3.95M and bringing the position to 503,640 shares worth $5.73M. The position accounts for ﹤0.01% of the portfolio, ranked #3363.

Bank of America first reported a position in ANGO in Q2 2013 and has held it in 52 quarters since. 147 funds tracked by Wall St. Rank hold ANGO as of Q1 2026.

Bank of America held 503,640 shares of AngioDynamics worth $5.73M as of Q1 2026.
Bank of America bought 364,763 AngioDynamics shares in Q1 2026, an estimated $3.95M.
AngioDynamics made up ﹤0.01% of Bank of America's portfolio in Q1 2026, its #3363 holding.
Bank of America first reported a position in AngioDynamics in Q2 2013 and has held it in 52 quarters since.
147 funds tracked by Wall St. Rank held AngioDynamics as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.